Multidisciplinary Management of Chronic Limb Threatening Ischemia
- PMID: 39691331
- PMCID: PMC11646918
- DOI: 10.1016/j.jaccas.2024.102717
Multidisciplinary Management of Chronic Limb Threatening Ischemia
Abstract
Patients with chronic limb threatening ischemia are at high risk for cardiovascular events, mortality, and adverse limb events. A 62-year-old man with diabetes and peripheral artery disease presented with a new foot ulcer with suspicion of infection. Leveraging evidence-based practices, a multidisciplinary team conducted a prompt and thorough evaluation. This collaborative approach facilitated comprehensive medical therapy and interventions for optimal limb outcomes and secondary prevention. The coexistence of diabetes, infection, and ischemia significantly augments the complexity of chronic limb threatening ischemia management. Addressing each of these components in concert with recent clinical practice guidelines and randomized trials can promote optimal outcomes.
Keywords: CLTI; PAD; WIfI; lipid; multidisciplinary team; rivaroxaban.
© 2024 The Authors.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures






References
-
- Gornik H.L., Aronow H.D., Goodney P.P., et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(24):e1313–e1410. doi: 10.1161/CIR.0000000000001251. - DOI - PubMed
-
- Bradbury A.W., Moakes C.A., Popplewell M., et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401(10390):1798–1809. doi: 10.1016/S0140-6736(23)00462-2. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources